Lv61
2090 积分 2024-01-18 加入
Prospective single-center study of chronic myeloid leukemia in chronic phase: switching from branded imatinib to a copy drug and back
3小时前
待确认
Comparison of adverse events following injection of original or generic docetaxel for the treatment of breast cancer
4小时前
待确认
Generic oncology drugs: are they all safe?
4小时前
待确认
Lorlatinib for advanced anaplastic lymphoma kinase–positive non–small cell lung cancer: Results of the IFCT-1803 LORLATU cohort
1个月前
已完结
TACE plus immune checkpoint inhibitor-based systemic therapies for hepatocellular carcinoma
1个月前
已完结
Duration of and time to response in oncology clinical trials from the perspective of the estimand framework
2个月前
已完结
Implications of High Tumor Burden on Chimeric Antigen Receptor T-Cell Immunotherapy
3个月前
已完结
Emerging Targeted Therapies and Strategies to Overcome Resistance in Biliary Tract Cancers
3个月前
已完结
Clinical Characteristics of Patients with Advanced ALK-Translocated Non-small Cell Lung Cancers and Long-Term Responses to Crizotinib (CRIZOLONG GFPC 05-19 Study)
4个月前
已完结
Non-small-cell lung cancer
4个月前
已完结
皖公网安备34019202002308
